Search

everythinglearnresearchcommunity

for

Search:↓

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Maidenhair fern extract may help treat COVID-19 symptoms.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Maidenhair fern extract might help treat COVID-19 symptoms, but more research is needed.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Sonidegib and vismodegib have different side effects and reporting patterns.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Rivaroxaban may cause hair loss.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Effective monitoring and prevention strategies are needed to manage the spread of hand, foot, and mouth disease in children.